Skip to main content
. 2023 Oct 9;2023(10):CD011769. doi: 10.1002/14651858.CD011769.pub2

10. Neurohormones versus placebo: adverse effects data that could not be used in the meta‐analysis.

Name of study Short‐/medium‐/long‐term outcomes Group 1 sample size Group 1 sample size Group 1 resultsMean (standard deviation) Group 2 resultsMean (standard deviation) Other data Notes
Sikich 2013 Short‐term oxytocin (max 24 IU children 3‐10 years or max 32 IU children 11‐17 years) adverse effects (metabolic) 11 13 0.64 (1.95) 1.09 (1.14) Skewed